Intensive BP control did not cut CV events in diabetes
CHICAGO — Targeting systolic blood pressure of less than 120 mm Hg did not reduce major cardiovascular events in patients with diabetes and high CV risk vs. a target of less than 140 mm Hg.
The results of a prespecified meta-analysis indicated that intensive BP lowering may decrease risk for major CV events in this population, but the OPTIMAL-DIABETES trial was deemed neutral, according to data presented at the American Heart Association Scientific Sessions and simultaneously published in The New England Journal of Medicine.
“The optimal systolic blood pressure target in patients with type 2